$ACI

Albertsons® Companies, Inc. Reports Second Quarter Fiscal 2026 R

Albertsons Companies (ACI) reported Q2 2026 results: identical sales fell 0.8%, digital sales rose 11%, net income was $52M ($0.11 per share), and adjusted net income was $179M ($0.36 per share). The company launched a business review to improve performance and shareholder returns. Net sales decreased 0.1% to $18.9B, and adjusted EBITDA was $784M. The company suspended its fiscal 2026 outlook until the review is complete.

Original reporting
Published Oct 13, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 12:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ACI
Bearish
high confidence
Mentioned
$ACI
Relevance
8/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ACIBearishHigh
01

Why it matters

The earnings release provides fresh data on sales trends, margins, and capital allocation, informing short‑term trading decisions.

02

Market read

First‑report earnings numbers for a large-cap retailer; likely to move the stock and influence the retail sector.

03

What to watch

Improved pharmacy margins and ongoing dividend payments may support valuation.

Relevance 8/10Novelty 8/10Timing: today

Background

Albertsons is a major U.S. food and drug retailer with over 2,200 stores.

Company-level read

Ticker impact

$ACIBearishHigh confidence
Context

Albertsons reported Q2 FY2026 results with declining identical sales, modest net income and no outlook guidance.

Expected impact

downward pressure as investors digest weaker sales and absence of forward guidance

Evidence & confidence

Revenue fell 0.1% YoY, identical sales down 0.8%, and the company halted outlook guidance, which typically triggers a sell‑off.

Market effects

Grocery and pharmacy retailers may see broader scrutiny on sales trends and margin pressure.

U.S. consumer‑discretionary sector could face slight downside as a large retailer reports weak sales.

Limited; primarily affects U.S. retail equities.

Counterpoint

If digital sales growth sustains, the stock could rebound on long‑term upside despite short‑term miss.

Key entities

  • Albertsons Companies, Inc.

    U.S. grocery retailer reporting Q2 FY2026 results.

  • Susan Morris

    CEO of Albertsons, quoted on performance and turnaround plan.

Related articles

$ACIMed

Transcript: Albertsons Companies Q2 2026 Earnings Conference Call - Albertsons Companies (NYSE:ACI)

Albertsons (NYSE:ACI) reported Q2 2026 identical sales down 0.8%, adjusted EBITDA $784M, and adjusted EPS $0.36. E-commerce sales grew 11%, while pharmacy sales remained strong. The company aims for $2B in cost savings over three years and is reviewing its business to enhance shareholder value. Albertsons generated $1.2B in operating cash flow and repurchased $400M in shares in the first half of 2026.

$ACIMedAI 8/10

Albertsons suspends fiscal 2026 guidance, launches business review Q2

Albertsons reported a 69% drop in Q2 net income to $51.5M, with sales down 0.1% to $18.89B. Adjusted EPS of $0.36 and revenue beat analyst estimates. The company suspended fiscal 2026 guidance and launched a business review to cut costs and improve strategy, targeting an investor day in spring 2027. Albertsons also declared a $0.17 quarterly dividend and repurchased 26M shares for $387.6M. The company is pursuing a $9.3B lawsuit against Kroger over a failed merger.

$ACIHigh

US grocer Albertsons pulls annual outlook, accelerates turnaround efforts

Albertsons withdrew its fiscal 2026 outlook and announced a business review to cut costs, lower prices, and boost sales. The grocer faces challenges from cautious consumer spending and market share losses. CEO Susan Morris and Executive Chair Meg Whitman aim to accelerate turnaround efforts. Shares rose 2% on Tuesday, despite a 27% decline year-to-date. Q2 adjusted profit beat estimates at $0.36 per share.